AdjuderaCommencer

Attribution

Assessment of applications of candidates (LOT 3)

Langue d’origine: anglais

Suivre cette ficheAvec Adjudera Pro, soyez alerté avant qu’un marché n’arrive à échéance.
Acheteur
European Medicines Agency, MED - European Medicines Agency
Titulaires
Core consulting S.p.A, Hudson Belgium, PwC EU Services EESV European Economic Interest Grouping
Montant du marché
1 236 200 €
Publié le
10 oct. 2025
Attribution
6 nov. 2024
Début d'exécution
6 nov. 2024
Fin du marché
5 nov. 2026estimée
Secteur
Services aux entreprises et de gestion
Région
Groot-Amsterdam
Source
Avis d'origine sur TED (671177-2025)

Autres attributions de cet acheteur

AttributionAcheteurTitulaireMontant du marchéPublié le
Data Management- Anonymization and redaction of documents and datasetsEuropean Medicines Agency, MED - European Medicines AgencyIQVIA Solutions Belgium B.V., Syneos Health Clinical Spain, S.L.U.—4 sept. 2026
LOT 7: Computational methods for comparison of molecular structural features in the context of medicines for rare diseasesEuropean Medicines Agency, MED - European Medicines AgencyIstituto di Ricerche Farmacologiche Mario Negri, KREATIS—1 sept. 2026
LOT 6: Innovative technologies for manufacturing and quality control of medicinesEuropean Medicines Agency, MED - European Medicines AgencyNATIONAL INSTITUTE FOR BIOPROCESSING RESEARCH AND TRAINING LIMITED, RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH, UNIVERSITA DEGLI STUDI DI MILANO—1 sept. 2026
LOT 5: Pharmacoepidemiological researchEuropean Medicines Agency, MED - European Medicines AgencyAgora Labs S.r.L., Biomedical Research Foundation, Academy of Athens – BRFAA, Certara France SARL +15 autres—1 sept. 2026
LOT 4: Qualitative researchEuropean Medicines Agency, MED - European Medicines AgencyNHG Finland Oy, NIVEL, Oracle France S.A.S. +2 autres—1 sept. 2026
LOT 3: Methodological/statistical researchEuropean Medicines Agency, MED - European Medicines AgencyAgentschap College ter Beoordeling van Geneesmiddelen, Austrian Agency for Health and Food Safety GmbH, Danish medicines Agency +8 autres—1 sept. 2026